<--- Back to Details
First PageDocument Content
Microbiology / Tuberculosis treatment / Extensively drug-resistant tuberculosis / Multi-drug-resistant tuberculosis / Rifampicin / Innogenetics / AIDS / Association of Public Health Laboratories / GeneXpert MTB/RIF / Tuberculosis / Medicine / Health
Date: 2014-12-24 13:25:42
Microbiology
Tuberculosis treatment
Extensively drug-resistant tuberculosis
Multi-drug-resistant tuberculosis
Rifampicin
Innogenetics
AIDS
Association of Public Health Laboratories
GeneXpert MTB/RIF
Tuberculosis
Medicine
Health

Regional Laboratories for Molecular Drug Susceptibility Testing

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 348,48 KB

Share Document on Facebook

Similar Documents

Tuberculosis / Clinical medicine / Health / Medicine / GeneXpert MTB/RIF / Multi-drug-resistant tuberculosis / Tuberculosis in India / Extensively drug-resistant tuberculosis

Microsoft Word - Uz_Success-Story_USAID ensures continued rapid TB testing in Uzbekistan_....docx

DocID: 1qxcf - View Document

Tuberculosis / Extensively drug-resistant tuberculosis / Rifampicin / Mycobacterium tuberculosis / DOTS / GeneXpert MTB/RIF / Tuberculosis management

Microsoft Word - Report_ICMR_Fellowship

DocID: 1pFTz - View Document

Tuberculosis / Latent tuberculosis / Tuberculosis diagnosis / Tuberculosis management / GeneXpert MTB/RIF / Multi-drug-resistant tuberculosis / Mantoux test / QuantiFERON / Isoniazid / BCG vaccine / DOTS / Rifabutin

DOC Document

DocID: 1oTAj - View Document

Chemistry / Viral load / HIV test / AIDS / HIV / CD4 / Assay / GeneXpert MTB/RIF / ELISA / HIV/AIDS / Biology / Medicine

2012 hiv/aids Diagnostics Technology Landscape SEMI-ANNUAL UPDATE october 2012

DocID: 1b0Lq - View Document

GeneXpert MTB/RIF / Tuberculosis / Health in India / Health

Xpert MTB/RIF: Evidence, WHO Policy Recommendations and Roadmap Elizabeth A Talbot MD Assoc Prof, Dartmouth and Medical Scientist, FIND

DocID: 1aT3U - View Document